These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 18328120

  • 1. A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension.
    Oparil S, Abate N, Chen E, Creager MA, Galet V, Jia G, Julius S, Lerman A, Lyle PA, Pool J, Tershakovec AM.
    Curr Med Res Opin; 2008 Apr; 24(4):1101-14. PubMed ID: 18328120
    [Abstract] [Full Text] [Related]

  • 2. Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients.
    Ruilope LM, Simpson RL, Toh J, Arcuri KE, Goldberg AI, Sweet CS.
    Blood Press; 1996 Jan; 5(1):32-40. PubMed ID: 8777471
    [Abstract] [Full Text] [Related]

  • 3. The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial.
    Pool JL, Glazer R, Crikelair N, Levy D.
    Clin Drug Investig; 2009 Jan; 29(12):791-802. PubMed ID: 19888785
    [Abstract] [Full Text] [Related]

  • 4. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
    Ambrosioni E, Bombelli M, Cerasola G, Cipollone F, Ferri C, Grazioli I, Leprotti C, Mancia G, Melzi G, Mugellini A, Mulè G, Palasciano G, Salvetti A, Trimarco B.
    Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
    [Abstract] [Full Text] [Related]

  • 5. Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension.
    Flack JM, Saunders E, Gradman A, Kraus WE, Lester FM, Pratt JH, Alderman M, Green S, Vargas R, Espenshade M, Ceesay P, Alexander J, Goldberg A, Study Group for Losartan in African Americans with Hypertension.
    Clin Ther; 2001 Aug; 23(8):1193-208. PubMed ID: 11558858
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A.
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of amlodipine camsylate/losartan 5/100-mg versus losartan/hydrochlorothiazide 100/12.5-mg fixed-dose combination in hypertensive patients nonresponsive to losartan 100-mg monotherapy.
    Suh SY, Ahn T, Bae JH, Lim DS, Lee SU, Kim YK, Hyon MS, Kim WH, Han KR, Park HK.
    Clin Ther; 2014 Oct 01; 36(10):1402-11. PubMed ID: 25146365
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 01; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 9. Long-term efficacy and tolerability of telmisartan as monotherapy and in combination with other antihypertensive medications.
    Neutel JM, Klein C, Meinicke TW, Schumacher H.
    Blood Press; 2002 May 01; 11(5):302-9. PubMed ID: 12458653
    [Abstract] [Full Text] [Related]

  • 10. Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: a post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trial.
    Lewin AJ, Weir MR.
    Clin Ther; 2008 Dec 01; 30(12):2354-65. PubMed ID: 19167594
    [Abstract] [Full Text] [Related]

  • 11. A comparison of initial treatment with losartan/HCTZ versus losartan monotherapy in chinese patients with mild to moderate essential hypertension.
    Li Y, Liu G, Jiang B, Gao R, Chen L, Su L, Li J.
    Int J Clin Pract; 2003 Oct 01; 57(8):673-7. PubMed ID: 14627176
    [Abstract] [Full Text] [Related]

  • 12. A study of losartan, alone or with hydrochlorothiazide vs nifedipine GITS in elderly patients with diastolic hypertension.
    Conlin PR, Elkins M, Liss C, Vrecenak AJ, Barr E, Edelman JM.
    J Hum Hypertens; 1998 Oct 01; 12(10):693-9. PubMed ID: 9819017
    [Abstract] [Full Text] [Related]

  • 13. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
    Neutel JM, Kolloch RE, Plouin PF, Meinicke TW, Schumacher H, OTELLOH Study Group.
    J Hum Hypertens; 2003 Aug 01; 17(8):569-75. PubMed ID: 12874615
    [Abstract] [Full Text] [Related]

  • 14. A comparison of the efficacy and safety of irbesartan/hydrochlorothiazide combination therapy with irbesartan monotherapy in the treatment of moderate or severe hypertension in diabetic and obese hypertensive patients: a post-hoc analysis review.
    Neutel JM.
    Postgrad Med; 2011 Jul 01; 123(4):126-34. PubMed ID: 21680997
    [Abstract] [Full Text] [Related]

  • 15. Achieving BP goals with valsartan and HCTZ alone and in combination: pooled analysis of two randomized, double-blind, placebo-controlled studies.
    Nash DT, Crikelair N, Zappe D.
    Curr Med Res Opin; 2008 Sep 01; 24(9):2617-26. PubMed ID: 18687165
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.
    Oparil S, Aurup P, Snavely D, Goldberg A.
    Am J Cardiol; 2001 Mar 15; 87(6):721-6. PubMed ID: 11249890
    [Abstract] [Full Text] [Related]

  • 17. Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension. Losartan Trial Investigators.
    Manolis AJ, Grossman E, Jelakovic B, Jacovides A, Bernhardi DC, Cabrera WJ, Watanabe LA, Barragan J, Matadamas N, Mendiola A, Woo KS, Zhu JR, Mejia AD, Bunt T, Dumortier T, Smith RD.
    Clin Ther; 2000 Oct 15; 22(10):1186-203. PubMed ID: 11110230
    [Abstract] [Full Text] [Related]

  • 18. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y.
    Clin Ther; 2005 Jul 15; 27(7):1013-21. PubMed ID: 16154480
    [Abstract] [Full Text] [Related]

  • 19. Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial.
    Schmieder RE, Philipp T, Guerediaga J, Gorostidi M, Bush C, Keefe DL.
    J Hypertens; 2009 Jul 15; 27(7):1493-501. PubMed ID: 19444142
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial.
    Sohn IS, Kim CJ, Oh BH, Hong TJ, Park CG, Kim BS, Chung WB, Investigators.
    Am J Cardiovasc Drugs; 2016 Apr 15; 16(2):129-38. PubMed ID: 26691333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.